# Liver segmental volumes and their relationship with 5-year prognostication

**Authors:** Damiano Catucci, Joris Hrycyk, Naomi Franziska Lange, Verena Carola Obmann, Annalisa Berzigotti, Michael Patrick Brönnimann, Lukas Zbinden, Kady Fischer, Dominik Paul Guensch, Lukas Ebner, Justus Roos, Andreas Christe, Adrian Thomas Huber

PMC · DOI: 10.1007/s00261-024-04552-w · Abdominal Radiology (New York) · 2024-09-10

## TL;DR

This study shows that liver volume ratios from CT scans can predict chronic liver disease and its 5-year outcomes.

## Contribution

The study introduces CRL-R and LSVR as novel CT-based biomarkers for CLD prognosis.

## Key findings

- CRL-R and LSVR significantly differ between CLD stages and healthy controls.
- Combined CRL-R and LSVR thresholds predict lower 5-year survival rates in CLD patients.
- CRL-R > 0.99 and LSVR > 0.37 show high sensitivity and specificity for advanced CLD.

## Abstract

This study aimed to analyze the predictive value of caudate to right lobe ratio (CRL-R) and liver segmental volume ratio (LSVR) for chronic liver disease (CLD) on routine abdominal CT scans and their association with 5-year decompensation- and transplant-free survival.

This retrospective study included 108 patients without CLD and 98 patients with biopsy-proven CLD. All patients underwent abdominal CT scans between 03/2015 and 08/2017. Patients with CLD were divided into three groups: early CLD (F0-F2; eCLD; n = 40), advanced CLD (F3-F4; aCLD; n = 20), and aCLD with clinically significant portal hypertension (aCLDPH; n = 38). CRL-R and LSVR were compared between groups using Kruskal–Wallis test and ROC analysis to determine cutoff-values. 5-year decompensation- and transplant-free survival were assessed by Kaplan–Meier curve analysis.

CRL-R and LSVR were significantly different between all groups (p < 0.001). A CRL-R cutoff-value of > 0.99 predicted aCLD with a sensitivity of 69% and a specificity of 80% (AUC = 0.75, p < 0.001), while LSVR > 0.37 had a sensitivity of 67% and a specificity of 84% (AUC = 0.80, p < 0.001). CLD-patients with both CRL-R > 0.99 and LSVR > 0.37 had a significantly lower probability of 5-year decompensation-free survival (31%) as well as lower probability of 5-year transplant-free survival (41%) than those with a CRL-R < 0.99 and/or LSVR < 0.37 (70%, 62%, p = 0.006, p = 0.038).

CRL-R and LSVR showed a high predictive value for CLD on routine abdominal CT scans. In patients with CLD, both CRL-R and LSVR may be combined and are associated with 5-year decompensation-free and transplant-free survival.

## Linked entities

- **Diseases:** portal hypertension (MONDO:0005080)

## Full-text entities

- **Genes:** IL31RA (interleukin 31 receptor A) [NCBI Gene 133396] {aka CRL, CRL3, GLM-R, GLMR, GPL, IL-31RA}
- **Diseases:** CLD (MESH:D008107), portal hypertension (MESH:D006975)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11821769/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11821769/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC11821769/full.md

---
Source: https://tomesphere.com/paper/PMC11821769